Journal article
A Phase 2 biomarker-enriched study of evofosfamide (TH-302) in patients with advanced melanoma.
Authors
McWhirter E; Hamid O; Chmielowski B; Carvajal RD; Jaffray DA; Driscoll B; Shek T; Yeung I; Keller H; McKee TD
Journal
Journal of Clinical Oncology, Vol. 33, No. 15_suppl, pp. tps9089–tps9089
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2015
DOI
10.1200/jco.2015.33.15_suppl.tps9089
ISSN
0732-183X